What this means
This is a plan for a study that has not started yet. It has not reported any results, so it cannot show whether the serum works or is safe.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 25–50
- Where
- 1 site, including California
The science
- Registered title
- Evaluate the Safety and Efficacy of a Topical Serum (AGE Serum) in Improving Visible Signs of Aging
- Trial ID
- NCT07216352 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Laxity; Skin
- What is tested
- AGE Serum
- Sponsor
- Goldman, Butterwick, Fitzpatrick and Groff
- Ages
- 25 Years to 50 Years
- Dates
- First posted Oct 14, 2025 · updated Oct 28, 2025
Registry summary
The primary objective is to evaluate the safety and efficacy of a topical serum (AGE serum) in improving visible signs of aging (e.g., fine lines, wrinkles, sagging, texture, radiance) on the full face and neck.The study will be conducted in non-menopausal female and male subjects who are on glucagon-like peptide-1 (GLP-1) agonist therapy for weight loss.
Sites (1)
- West Dermatology Research Center, San Diego, California, United States